- Company Overview for TAKEDA CAMBRIDGE LIMITED (03585995)
- Filing history for TAKEDA CAMBRIDGE LIMITED (03585995)
- People for TAKEDA CAMBRIDGE LIMITED (03585995)
- More for TAKEDA CAMBRIDGE LIMITED (03585995)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
26 Jun 2023 | CS01 | Confirmation statement made on 23 June 2023 with no updates | |
08 Apr 2023 | AA | Full accounts made up to 31 March 2022 | |
15 Dec 2022 | AP01 | Appointment of Mr Peter Michael Grubin as a director on 13 December 2022 | |
12 Sep 2022 | TM01 | Termination of appointment of Charmaine Linda Reid as a director on 31 August 2022 | |
27 Jun 2022 | CS01 | Confirmation statement made on 23 June 2022 with no updates | |
06 Apr 2022 | AA | Full accounts made up to 31 March 2021 | |
08 Jul 2021 | TM01 | Termination of appointment of David Isaacs as a director on 30 June 2021 | |
23 Jun 2021 | CS01 | Confirmation statement made on 23 June 2021 with no updates | |
28 Apr 2021 | AP01 | Appointment of Mr Marc Stuart Page as a director on 28 April 2021 | |
26 Mar 2021 | AA | Full accounts made up to 31 March 2020 | |
01 Oct 2020 | AP01 | Appointment of Mrs Charmaine Linda Reid as a director on 29 September 2020 | |
29 Sep 2020 | TM01 | Termination of appointment of Mark Conrad Fowler as a director on 25 September 2020 | |
23 Jun 2020 | CS01 | Confirmation statement made on 23 June 2020 with no updates | |
23 Dec 2019 | AA | Full accounts made up to 31 March 2019 | |
24 Jun 2019 | CS01 | Confirmation statement made on 23 June 2019 with updates | |
14 Jan 2019 | SH20 | Statement by Directors | |
14 Jan 2019 | SH19 |
Statement of capital on 14 January 2019
|
|
14 Jan 2019 | CAP-SS | Solvency Statement dated 14/01/19 | |
14 Jan 2019 | RESOLUTIONS |
Resolutions
|
|
27 Dec 2018 | AA | Full accounts made up to 31 March 2018 | |
27 Jun 2018 | CS01 | Confirmation statement made on 23 June 2018 with no updates | |
04 Jan 2018 | AP01 | Appointment of Mr Andrew Raymond Spicer as a director on 19 December 2017 | |
21 Dec 2017 | AA | Full accounts made up to 31 March 2017 | |
28 Jun 2017 | CS01 | Confirmation statement made on 23 June 2017 with updates | |
28 Jun 2017 | PSC02 | Notification of Takeda Pharmaceutical Company Limited as a person with significant control on 6 April 2016 |